Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIEHS

Farnesoid Activated Receptor Polypeptides,And Ucleic Acid Encoding The Same

  • Read more about Farnesoid Activated Receptor Polypeptides,And Ucleic Acid Encoding The Same
Canada
2210190
Filed on 1995-12-28

Farnesoid Activated Receptor Polypeptides,And Ucleic Acid Encoding The Same

  • Read more about Farnesoid Activated Receptor Polypeptides,And Ucleic Acid Encoding The Same
Japan
521693/96
Filed on 1995-12-28

Farnesoid Activated Receptor Polypeptides,And Ucleic Acid Encoding The Same

  • Read more about Farnesoid Activated Receptor Polypeptides,And Ucleic Acid Encoding The Same
Australia
45073/00
Filed on 2000-07-04

A farnesoid activated receptor (FAR) and method for screening for modulators of processes mediated by the FAR

  • Read more about A farnesoid activated receptor (FAR) and method for screening for modulators of processes mediated by the FAR
European Patent
95943987.8
Filed on 1995-12-28

Farnesoid Activated Receptor Polypeptides,And Ucleic Acid Encoding The Same

  • Read more about Farnesoid Activated Receptor Polypeptides,And Ucleic Acid Encoding The Same
Patent Cooperation Treaty
PCT/US95/017023
Filed on 1995-12-28

Compositions And Methods For Diagnostics And Therapeutics For Hydrocephalus

  • Read more about Compositions And Methods For Diagnostics And Therapeutics For Hydrocephalus
Patent Cooperation Treaty
PCT/US03/12348
Filed on 2003-04-18

Non-Steroidal Anti-Inflammatory Drug Related Gene With Anti-Tumorigenic Properties

  • Read more about Non-Steroidal Anti-Inflammatory Drug Related Gene With Anti-Tumorigenic Properties
US Patent 7,141,661
Filed on 2003-08-15

Use of Transgene Encoding a Vertebrate Phytase to Increase Capacity to Utilize Phytic Acid in Livestock Feed

  • Read more about Use of Transgene Encoding a Vertebrate Phytase to Increase Capacity to Utilize Phytic Acid in Livestock Feed
US Patent 7,351,580
Filed on 2003-07-03

Mutated Constitutively Active Nuclear Orphan Receptor

  • Read more about Mutated Constitutively Active Nuclear Orphan Receptor
Patent Cooperation Treaty
PCT/US03/05163
Filed on 2003-02-19

REGULATION OF INS (3456) P4SIGNALLING BE A REVERSIBLE KINASE/ PHOSPHATASE AND METHODS AND COMPOSITIONS RELATED THERETO

  • Read more about REGULATION OF INS (3456) P4SIGNALLING BE A REVERSIBLE KINASE/ PHOSPHATASE AND METHODS AND COMPOSITIONS RELATED THERETO
Patent Cooperation Treaty
PCT/US03/08641
Filed on 2003-03-18

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIEHS
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health